Cargando…

Authorization of the first COVID-19 emergency vaccines: The matters arising

Detalles Bibliográficos
Autores principales:	Adedokun, Kamoru A., Kamorudeen, Ramat T., Bello, Ibrahim O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Leibniz Research Centre for Working Environment and Human Factors 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056048/ https://www.ncbi.nlm.nih.gov/pubmed/33883989 http://dx.doi.org/10.17179/excli2021-3384

Ejemplares similares

A close look at the biology of SARS-CoV-2, and the potential influence of weather conditions and seasons on COVID-19 case spread
por: Adedokun, Kamoru A., et al.
Publicado: (2020)

Addressing the global surge of COVID-19 cases: Insights from diagnostics, improved treatment strategies, vaccine development and application
por: Adedokun, Kamoru A., et al.
Publicado: (2021)

Early stage nonclinical pulmonary disorder in COVID-19 may present asymptomatic and fuel the contagion
por: Adedokun, Kamoru Ademola
Publicado: (2021)

In Response to Author: COVID-19 and T Cells: Do T Cells Really Matter?
por: Vadi, Sonali, et al.
Publicado: (2023)

Author’s Reply—COVID-19 vaccination and torsades de pointes
por: Abrich, Victor, et al.
Publicado: (2022)

The emergency use authorization for COVID‐19 convalescent plasma reduced mortality
por: Paneth, Nigel, et al.
Publicado: (2023)

Emergency use authorization (EUA), conditional marketing authorization (CMA), and the precautionary principle at the time of COVID-19 pandemic
por: Roncati, Luca, et al.
Publicado: (2021)

Pilomatrixoma arising from maxillary sinus – First of its kind
por: Sruthi, T. R., et al.
Publicado: (2019)

Authors’ Reply to Sprengholz and Betsch: “Willingness to Pay for a COVID-19 Vaccine”
por: García, Leidy Y., et al.
Publicado: (2021)

Non-invasive respiratory supports on inspiratory effort in COVID-19: How and when is it matter of selection? Author's reply.
por: Schifino, Gioacchino, et al.
Publicado: (2022)

On COVID-19 and Matters Arising
por: Ogundiran, Akin
Publicado: (2020)

Could nucleocapsid be a next-generation COVID-19 vaccine candidate – author's reply
por: Oronsky, Bryan, et al.
Publicado: (2022)

Author's reply
por: Al-Orainey, Ibrahim O.
Publicado: (2009)

New‐onset lichen planus arising after COVID‐19 vaccination
por: Zagaria, Orlando, et al.
Publicado: (2022)

Learning with the COVID-19 pandemic mistakes: Facing the progression of the first cases of Monkeypox in Brazil. Authors' reply
por: Boschiero, M.N., et al.
Publicado: (2023)

Health Economic Impact of First Pass Success: An Asia-Pacific Cost Analysis of the ARISE II Study
por: Yeo, Leonard, et al.
Publicado: (2021)

Placebo-controlled trials with COVID-19 vaccines: participants first
por: Dal-Ré, Rafael
Publicado: (2021)

Emerging technologies and COVID-19 digital vaccination certificates and passports
por: Mbunge, Elliot, et al.
Publicado: (2021)

Author response to comment on: Premenstrual and menstrual changes reported after COVID-19 vaccination: The EVA project
por: Baena-García, Laura, et al.
Publicado: (2022)

Author's Reply
por: Aliyu, Ibrahim, et al.
Publicado: (2017)

Plasma hemoglobin in COVID-19: authors’ reply
por: Lancman, Guido, et al.
Publicado: (2020)

Authors' Response: COVID-19 in Children with Asthma
por: Chatziparasidis, Grigorios, et al.
Publicado: (2021)

Remdesivir for the treatment of COVID-19: author's response
por: Lee, Todd C., et al.
Publicado: (2023)

Who should get the vaccine first? A glimpse at COVID-19 vaccination prioritization strategies
por: Askarian, Mehrdad, et al.
Publicado: (2021)

Authors’ response: Re: Reifferscheid et al., “COVID-19 vaccine uptake and intention during pregnancy in Canada”
por: MacDonald, Shannon E., et al.
Publicado: (2022)

Characteristics associated with serological COVID-19 vaccine response and durability in an older population with significant comorbidity: author's response
por: Søgaard, Ole Schmeltz
Publicado: (2022)

Author's reply. “Immunogenicity, effectiveness and safety of COVID-19 vaccine in older adults living in nursing homes: Comment”
por: Meijide Míguez, Héctor, et al.
Publicado: (2023)

Thrombocytopenia in COVID-19: pathophysiology matters
por: Gavriilaki, Eleni, et al.
Publicado: (2020)

'Post-COVID-19 chronic symptoms' – Author's reply
por: Davido, Benjamin, et al.
Publicado: (2021)

‘Treatment of COVID-19 with convalescent plasma’ – Author’s reply
por: Wooding, Denise J., et al.
Publicado: (2021)

Rethinking the Current Older-people-first Policy for COVID-19 Vaccination in Japan
por: Matsui, Kenji, et al.
Publicado: (2021)

‘Post-COVID-19 syndrome and humoral response association after one year in vaccinated and unvaccinated patients’: authors' response
por: Peghin, Maddalena, et al.
Publicado: (2022)

Re: Comments on “Recurrent Aseptic Meningoencephalitis Following BNT162b2 Vaccination for COVID-19”: The Authors Respond
por: Kang, Kyusik, et al.
Publicado: (2023)

Understanding the Complex Milieu of Epithelial-Mesenchymal Transition in Cancer Metastasis: New Insight Into the Roles of Transcription Factors
por: Imodoye, Sikiru O., et al.
Publicado: (2021)

Resurgence of “bow and arrow” related ocular trauma: Collateral damage arising from COVID-19 lockdown in India?
por: Bapaye, Maneesh M, et al.
Publicado: (2020)

Authors Reply
por: Ataş, Halil, et al.
Publicado: (2015)

Author reply to “Cancer causes emergency home visits”
por: Kuroda, Kaku, et al.
Publicado: (2021)

Author`s Reply
por: Çaldır, Mehmet Vedat, et al.
Publicado: (2017)

The Authors Reply
por: Andeen, Nicole K., et al.
Publicado: (2020)

Prolonged use of Internet and gaming among treatment seekers arising out of social restrictions related to COVID‐19 pandemic
por: Higuchi, Susumu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b4j7l14hs43k6f12k5k4tj01k4